The market for continuous glucose monitoring (CGM) devices is actively growing and gaining increasing importance in the healthcare industry. As of 2023, its volume has exceeded $ 5 billion, and the projections indicate that it will continue its dynamic growth.
This growth is driven by several key factors: the increasing number of people with diabetes, increased awareness of the importance of continuous blood sugar control, and rapid advances in technology, including the integration of CGM devices with mobile platforms and artificial intelligence systems. All of this contributes to improving the accuracy and user-friendliness of these devices.
The prospects for business in this niche are wide open. The market needs innovations and new solutions that can improve people's quality of life and offer them more affordable and effective ways to manage diabetes. Companies entering the market in this rapidly growing industry have an excellent chance of success.
